Similar articles

• Glucagon secretion during the development of insulin-secreting tumors induced by streptozotocin and nicotinamide.

  Yoshino G, Kazumi T, Morita S, Kobayashi N, Terashi K, Baba S. Yoshino G, et al. Endocrinol Jpn. 1979 Dec;26(6):655-60. doi: 10.1507/endocrj1954.26.655. Endocrinol Jpn. 1979. PMID: 232037
• [Biochemical studies on rats in the course of the induction of insulin-secreting islet cell tumors by streptozotocin (author's transl)].

  Kazumi T. Kazumi T. Nihon Naibunpi Gakkai Zasshi. 1978 Nov 20;54(11):1290-305. doi: 10.1507/endocrine1927.54.11_1290. Nihon Naibunpi Gakkai Zasshi. 1978. PMID: 214356 Japanese. No abstract available.
• Insulin release from the isolated perfused rat pancreas containing insulinomata induced by streptozotocin and nicotinamide: effects of glucose and responses to tumor removal.

  Kazumi T, Sakamoto C, Ohki A, Yoshino G, Otsuki M, Baba S. Kazumi T, et al. Endocrinology. 1981 Aug;109(2):607-10. doi: 10.1210/endo-109-2-607. Endocrinology. 1981. PMID: 6265193
• Peptide-secreting tumours with special reference to the pancreas.

  Sircus W. Sircus W. Gut. 1969 Jul;10(7):506-15. doi: 10.1136/gut.10.7.506. Gut. 1969. PMID: 4308902 Free PMC article. Review. No abstract available.
• The glucagonoma syndrome.

  Bloom SR, Polak JM. Bloom SR, et al. Adv Exp Med Biol. 1978;106:183-94. doi: 10.1007/978-1-4684-7248-6_23. Adv Exp Med Biol. 1978. PMID: 213958 Review. No abstract available.